IPSEN PHARMA BIOTECH

PARC D'ACTIVITE DE SIGNES, Signes, Provence Alpes Cote D Azur, France

Also known as:

ipb etablissement gammaster

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

Approvals

SFDA

Saudi Food and Drug Authority

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

Recent Approvals

DIPHERELINE P.R. POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 11.25 mg/vial

NPRA

2025-11-28

Somatuline Autogel 60mg, prolonged-release solution for injection in a pre-filled syringe

NPRA

2025-11-28

Somatuline Autogel 120mg, prolonged-release solution for injection in a pre-filled syringe

NPRA

2025-11-28

Somatuline Autogel 90mg, prolonged-release solution for injection in a pre-filled syringe

NPRA

2025-11-28

DIPHERELINE P.R. 3.75MG

NPRA

2025-11-28

DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection

SFDA

2025-07-18

DIPHERELINE P.R. 3 mg Powder for Suspension for Injection

SFDA

2025-07-18

DIPHERELINE 0.1 MG POWDER FOR SOLUTION FOR INJECTION / INFUSION

SFDA

2025-07-18

SOMATULINE AUTOGEL 120 MG SOLUTION FOR INJECTION IN PRE-FILLE

SFDA

2025-07-18

SOMATULINE AUTOGEL 60 MG SOLUTION FOR INJECTION IN PRE-FILLE

SFDA

2025-07-18

News

No news articles found

Back to Organizations